Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Konstantin Khetchoumian

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Advances in Experimental Medicine and Biology|May 1, 2013
TRIM involvement in transcriptional regulationFlorence Cammas, Konstantin Khetchoumian, Pierre Chambon, et al.
The Journal of Biological Chemistry|July 20, 2011
Tripartite motif 24 (Trim24/Tif1α) tumor suppressor protein is a novel negative regulator of interferon (IFN)/signal transducers and activators of transcription (STAT) signaling pathway acting through retinoic acid receptor α (Rarα) inhibitionJohan Tisserand, Konstantin Khetchoumian, Christelle Thibault, et al.
Cell Cycle (Georgetown, Tex.)|November 26, 2008
Trim24 (Tif1 alpha): an essential 'brake' for retinoic acid-induced transcription to prevent liver cancerKonstantin Khetchoumian, Marius Teletin, Johan Tisserand, et al.
Molecular Endocrinology (Baltimore, Md.)|December 3, 2005
Transcriptional intermediary factor 1alpha mediates physical interaction and functional synergy between the coactivator-associated arginine methyltransferase 1 and glucocorticoid receptor-interacting protein 1 nuclear receptor coactivatorsCatherine Teyssier, Chen-Yin Ou, Konstantin Khetchoumian, et al.
Nature Genetics|January 24, 2018
Pioneer factor Pax7 deploys a stable enhancer repertoire for specification of cell fateAlexandre Mayran, Konstantin Khetchoumian, Fadi Hariri, et al.
Nature Communications|September 5, 2019
Pituitary cell translation and secretory capacities are enhanced cell autonomously by the transcription factor Creb3l2Konstantin Khetchoumian, Aurélio Balsalobre, Alexandre Mayran, et al.
The Journal of Biological Chemistry|August 24, 2004
TIF1delta, a novel HP1-interacting member of the transcriptional intermediary factor 1 (TIF1) family expressed by elongating spermatidsKonstantin Khetchoumian, Marius Teletin, Manuel Mark, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2008
Arterial calcifications and increased expression of vitamin D receptor targets in mice lacking TIF1alphaMihaela Ignat, Marius Teletin, Johan Tisserand, et al.
Nature Communications|August 25, 2019
Pioneer and nonpioneer factor cooperation drives lineage specific chromatin openingAlexandre Mayran, Kevin Sochodolsky, Konstantin Khetchoumian, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 1, 2016
Development of a methodology for in vivo follow-up of hepatocellular carcinoma in hepatocyte specific Trim24-null mice treated with myo-inositol trispyrophosphateMihaela Ignat, Cherif Youssef Akladios, Véronique Lindner, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Advances in Experimental Medicine and Biology|May 1, 2013
TRIM involvement in transcriptional regulationFlorence Cammas, Konstantin Khetchoumian, Pierre Chambon, et al.
The Journal of Biological Chemistry|July 20, 2011
Tripartite motif 24 (Trim24/Tif1α) tumor suppressor protein is a novel negative regulator of interferon (IFN)/signal transducers and activators of transcription (STAT) signaling pathway acting through retinoic acid receptor α (Rarα) inhibitionJohan Tisserand, Konstantin Khetchoumian, Christelle Thibault, et al.
Cell Cycle (Georgetown, Tex.)|November 26, 2008
Trim24 (Tif1 alpha): an essential 'brake' for retinoic acid-induced transcription to prevent liver cancerKonstantin Khetchoumian, Marius Teletin, Johan Tisserand, et al.
Molecular Endocrinology (Baltimore, Md.)|December 3, 2005
Transcriptional intermediary factor 1alpha mediates physical interaction and functional synergy between the coactivator-associated arginine methyltransferase 1 and glucocorticoid receptor-interacting protein 1 nuclear receptor coactivatorsCatherine Teyssier, Chen-Yin Ou, Konstantin Khetchoumian, et al.
Nature Genetics|January 24, 2018
Pioneer factor Pax7 deploys a stable enhancer repertoire for specification of cell fateAlexandre Mayran, Konstantin Khetchoumian, Fadi Hariri, et al.
Nature Communications|September 5, 2019
Pituitary cell translation and secretory capacities are enhanced cell autonomously by the transcription factor Creb3l2Konstantin Khetchoumian, Aurélio Balsalobre, Alexandre Mayran, et al.
The Journal of Biological Chemistry|August 24, 2004
TIF1delta, a novel HP1-interacting member of the transcriptional intermediary factor 1 (TIF1) family expressed by elongating spermatidsKonstantin Khetchoumian, Marius Teletin, Manuel Mark, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2008
Arterial calcifications and increased expression of vitamin D receptor targets in mice lacking TIF1alphaMihaela Ignat, Marius Teletin, Johan Tisserand, et al.
Nature Communications|August 25, 2019
Pioneer and nonpioneer factor cooperation drives lineage specific chromatin openingAlexandre Mayran, Kevin Sochodolsky, Konstantin Khetchoumian, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 1, 2016
Development of a methodology for in vivo follow-up of hepatocellular carcinoma in hepatocyte specific Trim24-null mice treated with myo-inositol trispyrophosphateMihaela Ignat, Cherif Youssef Akladios, Véronique Lindner, et al.
Pageof 2